HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ZYC 5

structure in first source

Also Known As:

(17beta)-2-(1-adamantyl)-estra-1,3,5(10)-triene-3,17-diol; ZYC-5

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Cai, Zu Yun: 1 article (04/2002)
2.	Covey, Douglas F: 1 article (04/2002)
3.	Dugan, Laura L: 1 article (04/2002)
4.	Kim-Han, Jeong Sook: 1 article (04/2002)
5.	Rothman, Steven M: 1 article (04/2002)
6.	Thio, Liu Lin: 1 article (04/2002)
7.	Xia, Shuli: 1 article (04/2002)

Related Diseases

1.	Necrosis 04/01/2002 - "We synthesized an estrogen analog, ZYC-5, lacking activity at the classical estrogen receptor and examined its neuroprotective potential against necrosis induced by N-methyl-d-aspartate (NMDA) and apoptosis/necrosis induced by the NMDA receptor antagonist (+)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid (CPP). "

Related Drugs and Biologics

1.	Estradiol Congeners (Synthetic Estrogens)
2.	N-Methylaspartate (NMDA)
3.	N-Methyl-D-Aspartate Receptors (NMDA Receptors)
4.	Estrogen Receptors
5.	phosphonic acid
6.	6-chloro-2-(1-piperazinyl)pyrazine (CPP)